Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

The Interventional Pharmacoeconomic Toolbox Panel Discussion

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Opportunities to Optimize Cancer Policies Panel Discussion

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Feb
10
Today In Oncology
HPV Testing During Cervical Cancer Screening Potential Convenient and Noninvasive Method
Guidelines Harmonize Pan-Tumor Pathologic Response to Neoadjuvant Therapy
Tissue-Free ctDNA and Outcomes in Patients With Colorectal Cancer Receiving FOLFOX-Based Adjuvant Therapy
Ultraprocessed Food Associated With Increased Mortality Risk in Cancer Survivors
A Paradigm Shift In Treating Adult AML?
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo